InMode Ltd. Stock price

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
21.61 USD +1.93% Intraday chart for InMode Ltd. +1.79% -2.83%
Sales 2024 * 499M Sales 2025 * 540M Capitalization 1.82B
Net income 2024 * 205M Net income 2025 * 221M EV / Sales 2024 * 1.62 x
Net cash position 2024 * 1.01B Net cash position 2025 * 1.27B EV / Sales 2025 * 1.02 x
P/E ratio 2024 *
9.08 x
P/E ratio 2025 *
8.52 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.47%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.93%
1 week+1.79%
Current month-1.77%
1 month-0.32%
3 months-4.13%
6 months-30.18%
Current year-2.83%
More quotes
1 week
20.41
Extreme 20.41
21.92
1 month
20.00
Extreme 20
23.46
Current year
19.70
Extreme 19.7
26.80
1 year
18.57
Extreme 18.57
48.25
3 years
18.57
Extreme 18.57
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 08-01-01
Chief Executive Officer 71 08-01-01
Director of Finance/CFO 46 16-12-31
Members of the board TitleAgeSince
Director/Board Member 89 19-08-06
Chief Executive Officer 71 08-01-01
Founder 57 08-01-01
More insiders
Date Price Change Volume
24-03-28 21.61 +1.93% 1,012,826
24-03-27 21.2 +2.56% 821,667
24-03-26 20.67 +1.08% 681,519
24-03-25 20.45 0.00% 709,845
24-03-22 20.45 -3.67% 870,935

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women's health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
21.61 USD
Average target price
28.4 USD
Spread / Average Target
+31.42%
Consensus
  1. Stock
  2. Equities
  3. Stock InMode Ltd. - Nasdaq